Friday, September 13, 2013

Perjeta approved Neoadjuvant use

http://www.onclive.com/web-exclusives/In-Historic-Vote-on-Pertuzumab-ODAC-Suggests-Approval-of-First-Neoadjuvant-Regimen-for-Cancer

Despite my reservation for adjuvant drug research, neoadjuvant regimen is a different thing and much more exciting development to watch, and has the potential to revolutionalize and speed up cancer research.


http://www.cancernetwork.com/conference-reports/asco2013/breast-cancer-symposium/content/article/10165/2157691

How a neoadjuvant studies shows that biomarkers changed during the course of early breast cancer therapy.


http://www.inspire.com/groups/advanced-breast-cancer/discussion/long-interesting-clinical-trials/

Someone on inspire posted a lot of interesting clinical trials collated list.

No comments:

Post a Comment